Oruka Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $15.6M | $16.8M |
| FY2014 | — | $14.7M | $15.4M |
| FY2015 | — | $38.1M | $38.8M |
| FY2016 | — | $22.2M | $7.4M |
| FY2017 | — | $10.3M | $8.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $15.6M | $16.8M |
| FY2014 | — | $14.7M | $15.4M |
| FY2015 | — | $38.1M | $38.8M |
| FY2016 | — | $22.2M | $7.4M |
| FY2017 | — | $10.3M | $8.7M |